Seeking Safe and Stable At-Home Teeth Whitening Technologies with Low or Zero Peroxide Release
Specific Technical InnovationProject Size Range : Strategic project backed by large scale funding €
Innovation Need
Seeking Safe and Stable At-Home Teeth Whitening Technologies with Low or Zero Peroxide Release
- Anonymous Organization
- From European Union
- Responsive
- Project Size Range : Strategic project backed by large scale funding €
- Deadline at 30/11/2026
- Posted by
Desired outcome
A leading company in the dental industry is seeking to identify and validate novel, intrinsically safer teeth whitening technologies to launch a best-in-class whitening kit for both pharmacy and e-commerce channels.
The successful solution must feature low or non-oxygen/peroxide release to minimize free radical exposure, operate at a safe, enamel-friendly pH (> 5.5), and guarantee a strict shelf-life stability of at least 30 months without compromising efficacy.
We are open to various business relationships, with a strong preference for:
- Finished product supply / Private label manufacturing
- Joint Development (specifically for highly promising T4-T5 technologies)
- Licensing and Exclusivity agreements
Background
While many current teeth whitening products deliver rapid results, they often rely heavily on peroxide-driven oxygen release. These mechanisms generate free radicals that can cause enamel damage and hypersensitivity. Alternatively, some products utilize highly acidic formulations (pH < 5.5) that require complex protective measures for the consumer.
Our goal is to overcome this industry compromise. We are looking for breakthrough formulations or active ingredients that deliver clinical efficacy comparable to current market leaders, but utilizing significantly safer, low-oxygen, or peroxide-free mechanisms.
Details of the Innovation Need
Must-Have Requirements
- Safety First (Low Free Radicals):The technology must be non-hydrogen peroxide-based or utilize significantly lower levels of peroxide to strictly minimize free radical generation and oxygen usage.
- Critical Stability & Shelf-Life: The formulation and its efficacy must remain completely stable for at least 30 months. This is a critical evaluation criterion. Submissions must prove that active ingredients and pH do not degrade over time (demonstrable via real-time or accelerated 6-month testing).
- pH Requirements: The formulation must maintain a strict, stable pH > 5.5 to ensure enamel safety.
- Efficacy Benchmarking:Submissions must demonstrate proven whitening efficacy in vitro and in vivo (targeting an improvement of roughly 9 tones within 7 days). Slightly lower efficacy (e.g., 1 tone less or requiring up to 12 days) is acceptable only if the technology offers zero oxygen release.
- PAP Specifications: If the formula utilizes PAP (Phthalimidoperoxycaproic acid), it must be present at a minimum concentration of 2%.
- Regulatory Compliance:The solution must fully comply with EU cosmetic regulatory requirements for convenient at-home consumer use.
- Maturity:The proposed solution must be at a Technology Readiness Level (TRL) of > 5.
- Geographical Scope:Solutions must be commercially viable within Spain.
Nice-to-have
- Adjunct Synergies:The inclusion of adjunct technologies or devices (like LED lights or customized trays) and synergistic ingredients (like Hydroxyapatite) is highly welcome if they demonstrably enhance safety or efficacy.
- Cost Feasibility:Solutions must be cost-effective and highly feasible for a premium consumer retail price point.
Discarded solutions
- Unstable Formulations: Any formulation that fails to maintain a reliable pH > 5.5 over the required 30-month shelf life.
- Inconsistent Manufacturing: Solutions with limited stability data, poor batch-to-batch reproducibility, or inconsistent efficacy results.
- Whitening Strips: Due to historically low efficacy and poor consumer acceptance in our target market, strip formats are entirely out of scope.
Possible solution areas
- Teeth Whitening | Oral Care | Non-Peroxide | Low Oxygen Release | Free Radical Safety | PAP | Dental Aesthetics | Cosmetic Dentistry | Private Label Manufacturing
Related Keywords
About Us
Established mid-sized European healthcare and pharmaceutical group with a global distribution network across 40+ markets. Portfolio spans prescription therapeutics, OTC self-care, and specialized personal hygiene products.
Related Innovation Needs
About Innovation Needs
Innovation Needs on Innoget are directly posted and managed by its members as well as evaluation of proposals. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Help
Need help submitting your proposal or have questions regarding this Innovation Need?
Contact Innoget support
FAQs
In the solution proposal submission form:
- Do not disclose confidential information that is not properly protected
- Explain and focus on the benefits of applying and/ or developing your solution or technology rather than how you will get into it
- Provide information about specific expected outcome, implementation or developing timeline and costs
- Explain about your track record on projects you have successfully worked related to this technology field
- Use pre-defined buttons to give specific details about your proposal “Stage of development”, “Commercial Information” and “Intellectual Property Status”
The posting organization will directly evaluate your proposal. Please avoid sending spam as you can be blocked by posting members.
You are not asked to reveal any confidential information nor provide any solution that is not protected at this point. You just have to provide non-confidential information. After submitting your proposal, the posting company will evaluate it and directly connect with you. This is when if there is an interest you would request to sign an NDA with the company to keep the conversation ongoing.
Never reveal Confidential Information that it is not properly protected.
There is no need to sign an NDA. You are not asked to reveal any confidential information nor provide any solution that is not protected at this point. You just have to provide non-confidential information. After submitting your proposal the posting company will evaluate it and directly connect with you. This is when if there is an interest you would request to sign a Non-Disclosure Agreement (NDA) with the company to keep the conversation ongoing.
The average response rate for this user is 3 weeks
The posting company will directly contact you to open up discussions about your proposal and potential collaboration opportunities
You will be notified and provided with feedback from the posting company. You can always transform your proposal into a Technology Offer to present it to other members at no cost
